[1]
Pienwittayapun R, “ Safety and Effectiveness of Oral Deferiprone (GPO-L-ONE®) in Iron-Overload Children Patient with Thalassemia at Queen Sirikit National Institute of Child Health ”, j dept med ser, vol. 43, no. 3, pp. 108–113, Jun. 2018.